None listed
Conditions
Interventions
None listed
Sponsors
Woorisoft
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The criteria for selection were met by those who completed the voluntary written consent of the legal guardian to participate in the clinical trial, those who could follow the evaluation and guidelines of the clinical trial director, and those with normal intellectual function according to the Korean version of the Wexler Children’s Intelligence Test.
Exclusion criteria
Exclusion criteria: Those with disabilities or conditions other than ADHD (post-traumatic stress, psychosis, severe obsessive-compulsive disorder, severe depression), those who have difficulty using experimental products (physical deformities of hands or arms, prosthetic arms, etc.), those who have a history of drug abuse or dependence within six months, those who participated in other ADHD-related studies within 90 days of screening, those who are colorblind, those who have registered or are participating in the same study in their families, and those who were judged to be unfit to participate in the study were excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of change in Comprehensive Attention Test (CAT);Adverse events (frustration, headache, dizziness) | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of change in Korean ADHD Rating Scale (K-ARS);Rate of change in Korea-Child Behavior Checklist (K-CBCL);Rate of change in Korean Wechsler Intelligence Scale for Children-Fifth Edition (K-WISC-V);Rate of change in Frankfurter Aufmerkasamkeits Inventar (FAIR) | — |
Countries
Korea, Republic of
Contacts
Public ContactHojun Lee
Keimyung University Dongsan Hospital
Outcome results
None listed